Intranasal insulin (INI) treatment may improve motor skills and verbal fluency in patients with Parkinson disease (PD), according to a new study in PLOS ONE. The investigators conducted the study to ...
For patients with multiple sclerosis (MS) being treated with natalizumab, cognitive function improved from baseline to 1 year and improved significantly across all domains from baseline to 2 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results